Synaffix B.V.

Synaffix B.V. is a biotechnology company that develops ADC product candidates using its clinical-stage, site-specific ADC technology platform.

Photo of a final puzzle piece about to fit into a puzzle
Biotech

Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal

Elevation Oncology has agreed to pay Synaffix up to $368 million to access technology for use in its newly nominated HER3 antibody-drug conjugate.
Nick Paul Taylor Dec 12, 2024 9:19am
lots of hats

BigHat, Synaffix collab outfits AI science with ADC tech

Nov 4, 2024 11:07am
Photo of two hands shaking

After halting lead asset, Sotio signs $740M deal with Synaffix

Oct 16, 2023 3:00am
cash

Synaffix, MacroGenics crack open ADC pact, tack on $2.2B to deal

Mar 14, 2023 10:30am
pile of cash piggy bank money cash dollars bills spend

Amgen piles $2B more into pharma's ADC rush

Jan 5, 2023 10:20am
bird birds flying humingbirds

Hummingbird Bio buzzes Synaffix for $150M ADC licensing deal

Jan 4, 2023 11:05am